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Abstract: To be used in regenerative medicine, cells should be checked for 
various conditions, including cell aging. This study aimed to learn senescent 
profile and its relation to cell viability, proliferation and cell size in various 
passages, which were done in α-MEM-10% PRP medium, until senescence-
associated β-galactosidase (SA-β-Gal) positive cells were found. Stem cells 
were isolated from umbilical cord tissue by multiple harvest explant method, 
cultured in α-MEM-10% PRP until P-17 and stained using SA-β-Gal 
staining. Viability, Population Doubling Time (PDT), percentage SA-β-Gal 
(+) and cell size at 30% confluent and at senescent staining were analyzed. 
Passages with SA-β-Gal (+) and (-) were compared in term of viability, PDT 
and cell size at 30% confluent. Further, cell size at senescent staining between 
SA-β-Gal (+) and (-) groups were compared. Viability and PDT showed no 
significant difference between SA-β-Gal (+) and (-) groups, while cell size at 
30% confluence showed significant increase in SA-β-Gal (+) compared to (-) 
groups. Further, cell size in senescent staining showed significantly smaller 
cell size in SA-β-Gal (-) compared to SA-β-Gal (+) cells. Moreover, this 
study showed that even in SA-β-Gal (+) group, viability was greater 
than 91%, PDT was less than 2.1 days and cell size was less than 2602 
µm
2
. In conclusion, umbilical cord derived MSCs that were cultured in 
α-MEM-10% PRP began to undergo aging at P-10. Morphological 
criteria of UC-MSC aging were cell size greater than 2602 µm
2
 with a 
change in morphology toward a rounded shape.  
 
Keywords: Aging, Stem Cell, Umbilical Cord, Platelet Rich Plasma, 
Senescence 
 
Introduction 
Use of stem cells for regenerative medicine needs 
quality control of cell products that includes replicative 
senescent data. Cells, including adult stem cells can be 
cultured for limited passages before they undergo aging 
and this replication-capacity limit is known as “Hayflick 
limit” (Hayflick, 1965). Aging of cell causes irreversible 
proliferation-capacity ending that can be triggered by 
various factors. The factors can be categorized to four 
factors, i.e.,: DNA damage and shortening of telomere 
due to excessive linear chromosome replication, which is 
called replicative senescence; oxidative stress; oncogene 
activation; and other stressors, such as inadequate in 
vitro growth condition (Rai and Adam, 2012).
 
 
Stem cell long-term culture has a profound effect on 
proliferation and differentiation potential and cellular 
morphology. A study found that growth arrest on 
adipose tissue derived Mesenchymal Stem Cells (MSCs) 
occured after 138±20 days and 53.8±14.4 Cumulative 
Population Doublings (CPD). 
Cumulative population doublings were computed 
from cell seeding and harvest that were cumulated from 
all passages (Schellenberg et al., 2011). 
Passages in culture cause cell senescence. Since early 
passages, stem cells may show changes toward aging, 
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such as decrease in proliferation capacity, morphological 
changes, shortening of telomeres and functional 
impairments (Bonab et al., 2005; Wagner et al., 2010). 
Aging stem cells show characteristic morphological-
appearance as flattened large cells. Moreover, aging cells 
express senescence-associated beta galactosidase (SA-β-
Gal), which can be regarded as biomarker of aging cells 
(Schellenberg et al., 2013). Increase in SA-β-Gal activity 
could be observed since passage 6 (P-6) in bone marrow 
and adipose tissue derived stem cells, while in Umbilical 
Cord (UC) derived stem cells since passage 9 to 12 (P-9 
to P-12) (Hye et al., 2013). At P5 to P-12, bone marrow 
derived stem cells showed a decrease in clonogenicity 
and differentiation potential (Wagner et al., 2010).
 
For 
gene and cell therapy, a study suggested to use MSCs 
from P-2 to P-6, the younger the passage, the better 
(Bonab et al., 2005). Maximal population doublings 
before senescence depend on type and source of tissue, 
culture method and culture medium (Hye et al., 2013; 
Estrada et al., 2013). 
Studies on in vitro stem cell culture usually used Fetal 
Bovine Serum (FBS) supplemented media. As FBS 
contains xenoproteins that may cause rejection problems, 
alternatives to FBS were studied. Some studies on Platelet 
Rich Plasma (PRP) supplemented media showed that PRP 
can be used as alternative to FBS. Using UC sample, a 
study showed that PRP can replace FBS as culture-
medium supplement, as PRP showed comparable 
performance to FBS in cell proliferation and 
differentiation (Budiyanti et al., 2015). Another study 
reported that MSC isolation from UC using explant 
culture could be harvested several times and the technique 
was called multiple harvest explant method (Pawitan et al., 
2014a).   However, senescent profile of MSCs that were 
isolated using multiple harvest explant method in α-
minimal essential medium (α-MEM)-10% PRP has not 
been studied, especially in relation to senescence-
associated β-galactosidase (SA-β-Gal) staining and cell 
size. Therefore, this study was conducted to learn 
senescent profile and its relation to cell viability, 
proliferation and cell size in various passages, until SA-β-
Gal positive cells were found in cultures that were 
cultured in α-MEM-10% PRP medium. 
Materials and Methods 
This study was done in Stem Cell Medical 
Technology Integrated Service Unit, Cipto 
Mangunkusumo Central Hospital/Faculty of Medicine 
Universitas Indonesia, from April to November 2014. 
Ethical clearance was issued by the Ethical Committee 
of the Faculty of Medicine, Universitas Indonesia 
(No.665/UN2.F1/ETIK/2014). Stem cells for this study 
were isolated from an umbilical cord that was donated by 
a woman who underwent an elective Caesarean section 
and has signed the informed consent form.  
Procedure   
Stem cell isolation was done using modification of 
multiple harvest explant method (Pawitan et al., 2014a). 
In brief, UC was washed and immersed in 0.5% 
povidone iodine containing Phosphate Buffered Saline 
pH 7.4 (PBS) for 5 min, followed by washing in PBS. 
Umbilical arteries and vein were discarded and UC tissue 
was minced in complete medium to small pieces (2-5 
mm). Complete medium was penicillin/ streptomycin 
([Biosera LM-A4118/100] final concentration 100 U/mL), 
amphotericin B ([Gibco 15290-018] final concentration 
2500 ng/mL), 1% GlutaMAX and 10% PRP containing α-
MEM [Gibco 12000-014]. One piece of minced UC 
tissue was placed in a well of a 24 well-plate (area 1.9 
cm2 [Biolite]) and a drop of complete medium was 
added to the tissue (explant). All process was done under 
sterile condition. Further, the plate was incubated at 
37
o
C, 5% CO2 and was observed everyday during the 
Primary culture (P0) period. Observation was done to 
prevent the explant from drying by adding a necessary 
amount of medium. When the explant attached to the 
well, 0.2 mL fresh complete medium was added and 
medium change was done every 2-3 days. Observation 
was also done to detect cell growth. After cell growth 
was 70-80%, the cells were harvested using TrypLE 
Select (Gibco 12563-011).   
Harvested cells were re-cultured to P-1 in six 12-well 
plate (area 3.8 cm2 [Biolite]), with a seeding density of 
5000 viable cells/cm2. After 70-80% confluence, cells 
from two wells were harvested and cells from four wells 
were fixed and stained using senescent staining kit 
(Sigma CS0030-1KT). Senescent cells were SA-β-Gal 
positive, which showed blue-green color that was 
apparent after 12-16 h of incubation. Further, harvested 
cells were re-cultured in six 12-well plate again and 
again to yield P-2 until P-17. 
Cell Size Measurement 
At 30% confluence, cells from all wells were 
photographed (40×magnification) using inverted 
microscope at five random fields to measure cell size 
(area). Cell area was measured using AxioVision Rel.4.8 
program on the photograph (in µm
2
). For each passage, 
fifty randomly chosen fibroblastic (spindle shaped) cells 
were measured. 
Cells in SA-β-Gal-stained wells were photographed 
(100× magnification) using inverted microscope at five 
random fields to count SA-β-Gal (+) cells and all cells. 
Further, cell area of six randomly chosen SA-β-Gal (+) 
and (-) cells from each well was measured using 
AxioVision Rel.4.8 program on the photograph (in µm
2
).   
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Cell Viability Analysis 
Harvested cells were counted using improved 
Neubauer haemocytometer and checked for their 
viability by tryphan blue dye exclusion method. Ten µl 
of cell suspension was mixed with the same volume of 
0.4% trypan blue solution, inserted into the 
haemocytometer and after 1-2 min at room temperature, 
viable and non-viable cell-count was done. Further, cell 
viability (percentage of viable cells per total cells) was 
calculated for each passage. 
Data Collection and Analysis 
Data collected from P-1 to P-17 were: Time to 
confluence, viability, Population Doubling Time (PDT), 
cell size (at 30% confluence and at senescent staining) 
and percentage of senescent (SA-β-Gal +) cells. 
Senescent data were grouped into SA-β-Gal (+) and (-) 
passages. Passage-1 was not included as was regarded as 
heterogeneous. All data were tabulated and means and 
standard deviations were calculated, but when the data 
did not show normal distribution or non homogenous, 
median was analyzed. Further, Cumulative Population 
Doubling (CPD) at P-17 was calculated. 
Population doubling time was calculated using the 
equation: PDT= (t-t0) log2/ (log Nt-log Nt0), where Nt= 
total cell count at harvest, Nt0= viable cell count at seeding, 
t= time at harvest and t0= time at seeding. Cumulative 
population doubling was calculated by summing up all 
population doublings of all passages until P-17. 
Data analysis was done using Statistical Product and 
Service Solution (SPSS) version 16.0 program. 
Comparison of cell viability, PDT and cell size at 30% 
confluent between SA-β-Gal (+) and (-) groups were 
done using independent t test, when the data were 
appropriate for parametric analysis. Further, cell size at 
senescent staining between SA-β-Gal (+) and (-) groups 
from the same wells were compared using paired t test, 
when the data were appropriate for parametric analysis. 
For all comparisons, when the data were inappropriate 
for parametric tests, non parametric tests were done.  
Results 
Mean value of viability, PDT and cell size at 30% 
confluence can be seen in Table 1. Cumulative 
population doubling until P-17 was 61.23 times, 
cumulative culture time was 76 days and mean time to 
70-80% confluence was 4.6 days. Median (minimum-
maximum value) of viability and PDT of P-2 to P-17 
was 95.92 (90.73-99.73) % and 1.61 (0.99-2.02) days 
respectively. Positive SA-β-Gal cells were first found at 
P-10 with a median (minimum-maximum value) of 0 (0-
0.54) %. Therefore, the data were grouped according to 
SA-β-Gal (-) and (+), i.e. P-2 to P-9 and P-10 to P-17. 
Median (minimum-maximum value) of SA-β-Gal (+) 
cells from P-10 to P-17 was 0.54 (0-3.41) %. Viability, 
PDT and cell size at 30% confluence of UC MSCs in P-2 
to P-9 and P-10 to P-17 groups can be seen in Table 2.  
 
Table 1. Viability, PDT and cell size at 30% confluent of cells 
in P-2 to P-17 
Passage Viability PDT Cell size 
P-2 91.59 1.87 2188.64 
P-3 96.51 1.11 2803.78 
P-4 96.82 1.12 2911.45 
P-5 93.45 1.16 2575.72 
P-6 94.49 1.73 2229.75 
P-7 99.73 1.98 2100.49 
P-8 98.80 1.61 2677.63 
P-9 98.48 1.69 3079.98 
P-10 93.64 1.46 2797.60 
P-12 95.34 1.62 4051.48 
P-13 97.75 1.22 3664.33 
P-14 96.76 1.62 3588.15 
P-15 92.39 1.34 4384.95 
P-16 95.34 0.99 3624.64 
P-17 90.73 2.02 4527.19 
P- = Passage 
 
Table 2. Viability, PDT and cell size at 30% confluence of umbilical cord MSCs in P-2 to P-9 and P-10 to P-17 group 
  Group  n Mean  SD p Mean difference (95% CI)  
Viability  P-2 to P-9 87 96.23 2.84 0.71 1.27 (-1.62 - +4.17)  
 P-10 to P-17 87 94.96 2.54 
PDT P-2 to P-9 87 1.53 0.35 0.49 0.04 (-0.32 - +0.40)  
 P-10 to P-17 87 1.50 0.32 
Cell size P-2 to P-9 400 2571 363 0.00 1193 (-1694 - -692)  
  P-10 to P-17 400 3764 552 
PDT= Population Doubling Time, MSCs= Mesenchymal Stem Cells, P= passage, SD= Standard Deviation, p= p value, CI= Confidence Interval 
 
Table 3. Cell size of umbilical cord derived MSCs in SA-β-Gal (-) and (+) group 
Cell size Mean (SD) Difference (SD) 95% CI p 
SA-β-Gal (-) (n=36) 1860 (742) 2045 (1816) -2611 - -1479 0.00 
SA-β-Gal (+) (n=36) 3905 (1934) 
MSCs = Mesenchymal Stem Cells, SA-β-Gal = Senescence Associated-β-galactosidase, n = experiment number, SD = Standard Deviation, CI = 
Confidence Interval, p = p value 
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 P-2-100× (negative) P-9-100× (negative) 
          
 P10-200× (positive)  P17-100× (positive) 
 
Fig. 1. SA-β-Gal staining of mesenchymal stem cells from P-2, P-9, P-10 and P-17 
 
 
 
Fig. 2. Morphological appearance of UC-MSCs in SA-β-Gal staining (100×) UC-MSCs= umbilical cord derived mesenchymal stem 
cells, SA-β-Gal= senescence associated β-galactosidase, blue arrow= SA-β-Gal (+) cell, white arrow= SA-β-Gal (-) cell, 
inset= enlargement 
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Independent t test on viability and PDT showed no 
significant difference between P-2 to P-9 and P-10 to 
P-17 group, while cell size at 30% confluence showed 
a significant increase in P-10 to P-17 compared to P-2 
to P-9 group.  
Mean value and standard deviation of cell size of UC 
- MSCs in SA-β-Gal staining, difference between SA-β-
Gal (+) and (-) group, 95% confidence interval and p 
value of the difference can be seen in Table 3.           
Paired t test on cell size of UC MSCs showed 
significantly smaller cell size in SA-β-Gal (-) compared 
to SA-β-Gal (+) group (Table 3). However, data of SA-
β-Gal staining did not include data of P-11, as P-11 
culture had undergone retraction and was detached when 
it was stained. 
Figure 1 showed negative SA-β-Gal staining (P-2 and 
P-9) and positive SA-β-Gal staining (P-10 and P-17). 
Figure 2 showed morphological appearance of UC- 
MSCs in SA-β-Gal staining. An SA-β-Gal (+) cell (blue 
arrow) was larger and wider in diameter compared to an 
SA-β-Gal (-) cell that was more fibroblastic in shape. 
Discussion 
Passage caused UC - MSCs to undergo aging. Aging 
stem cells express β-Galactosidase due to increase in 
lisosomal activity. β-Galactosidase activity can be 
detected by adding 5-bromo-4-chloro-3-indolyl β-D-
galactopyranoside (X-Gal), a chromogenic substrate that 
upon cleavage gives rise to blue green precipitates 
(Dimri et al., 1995).  In this study, SA-β-Gal (+) cells 
began to be detected at P-10 and median (minimum-
maximum) value of positive cells was 0.54 (0-3.41) % 
that indicated the beginning of aging process. A study 
found that SA-β-Gal(+) cells in UC blood MSCs began 
to increase at P-9 to P-12 (Hye et al., 2013),
 
 while 
another study found 5-10% SA-β-Gal (+) cells in early 
passages of UC - MSCs, which increase between 38.2 ± 
9.4% in P-15 and 71.5±8.8% in P-21 (Scheers et al., 
2013).
 
Scheers et al. (2013) used DMEM-10% FBS with 
a seeding density of 1.10
4 
cells/cm
2
, while Hye el al. 
(2013) used α-MEM - 10% FBS with a seeding density 
of 5.10
5
 cells/cm
2 
and we used α-MEM- 10% PRP with a 
seeding density of 5000 cells/cm
2
. Further, a study 
showed that serum supplemented medium caused a fast 
increase in percentage of senescent cells from 
22.79 ± 0.77% in P-3 to 30.22 ± 11.07% in P-5 
(Swamynathan et al., 2014). 
Therefore, an increase in percentage of senescent 
UC-MSCs is influenced by culture medium and CPD, 
while seeding density influence PD. At higher seeding 
density, less PD is needed to attain confluence and 
causes lower CPD. Therefore, the higher the seeding 
density, the faster passage can be done and the number 
of passage for a certain CPD will be relatively higher. 
Seeding density in the study of Hye et al. (2013) was  
100 times of those in this study, while senescent in 
Hye et al. (2013)  study began at  P-9 to P-12, which 
seemed equivalent with the result of this study, but 
theoretically CPD in Hye et al. (2013) study was 
lower. Therefore, higher passage can’t be used as a 
reference; instead, CPD plays a more important role, 
as CPD is actually the reference for achievement of 
Hayflick’s limit, i.e., when the cells undergo aging 
and lose their ability to proliferate (Hayflick, 1965; 
Schellenberg et al., 2011; Bonab et al., 2005; Wagner 
et al., 2010). Therefore, aging at lower CPD indicates 
that the cells undergo faster aging.  
Moreover, the sample in Hye et al. (2013) study was 
UC blood that contained very few MSCs (Bieback et al., 
2004). Fewer initial number of MSCs theoretically 
causes more PD in P-0 to attain confluence compared to 
UC - MSCs, though PD in P-1 and higher passages are 
not influenced. However, high PD at P0 certainly 
increases overall CPD. 
In this study, viability at P-2 to P-17 was still very 
high with a median (minimum-maximum) of 95.92 
(90.73– 99.73) %. Another study on human Wharton’s 
jelly-derived stem cell viability found that viability at P-
10 was still > 82% and the highest viability was achieved 
at P-5 or P-6, which also showed an increase in 
proliferation rate (Garzón et al., 2012). Decreased cell 
viability is associated with cell necrosis. Na
+ 
and K
+ 
ions 
are cell viability markers and K
+
/Na
+ 
ratio is used as 
indicator of cell damage. An increase in Na
+
 and a 
decrease in K
+
 and Cl
-
 occur in cell death due to 
apoptosis, while high concentration of Cl
-
 is associated 
with cell necrosis. The study showed a decrease in 
intracellular K
+
 level at P-1 to P-3 followed by an 
increase until P-7 and a significant decrease beginning at 
P-8 and beyond. Cl
- 
level was significantly increased at 
P-7, P-8 and following passages.
 
These facts indicated 
that at P-1 to P-3, cell death was due to apoptosis, while 
beginning at P7-8, cell death was due to necrosis, which 
caused the highest viability at P5 and P6 (Garzón et al., 
2012). However, there was no data concerning 
physiological level of these ions in UC - MSCs. 
In this study, viability is checked by trypan blue dye 
exclusion method. We did not checked the viability 
using any other method, such as the 3-(4, 5-
dimethylthiazol-2-yl)-2-5-diphenoltetrazolium bromide 
(MTT) assay and this fact is the limitation of our study. 
Viability assay in our study might be influenced by 
trypan blue concentration and incubation time at cell 
counting procedure. A  study on human retinal pigment 
epithelial cells compared trypan blue 0.06 mg/mL, 0.6 
mg/mL and 4 mg/mL and found increased expression of 
p53 at trypan blue concentration of 4 mg/mL, while 
increase in p21 expression was found at all 
concentration. It was supposed that higher trypan blue 
Dian Mediana et al. / OnLine Journal of Biological Sciences 2015, 15 (3): 170.177 
DOI: 10.3844/ojbsci.2015.170.177 
 
175 
concentration caused toxicity that was indicated by a 
decrease in viability and alteration in gene expression 
that was related to apoptosis and growth arrest. 
Moreover, longer incubation caused cell death and a 
decrease in viable cell number (Kwok et al., 2004). This 
study used trypan blue concentration of 0.4% with 
trypan blue: Cell suspension ratio= 1:1 and incubation 
time 1-2 min, which was supposed to be non toxic and 
would not interfere with the result of this study.  
Proliferation capacity of MSCs decreases with 
passage. In this study, median (minimum-maximum 
value) of PDT for P-2 to P-17 was 1.61 (0.99-2.02) days, 
which indicated good proliferation capacity. Another 
study
 
found a decrease in MSC-PDT from 85±7.2 h at P-
0 to 11±1.2 h at P-7.  They calculated PDT at P0 as time 
needed from initial culture in DMEM-10% FBS until 
100% confluent and cell number was analyzed at several 
points during log phase (Karahuseyinoglu et al., 2007). 
Another study on DMEM - 10% FBS cultured UC-
MSCs at first 15-passages found that mean value ± SD 
of PDT at P-1 to P-15 was 3.1±0.4 days; a decrease in 
proliferation rate and final growth arrest occurred at 
CPD mean value ± SD of 33.7±2.1 doublings; whole 
culture period was 160.9±6.9 days, number of passages 
was 21±1.0 passages (Scheers et al., 2013).
 
Various 
factors may influence proliferation rate of MSCs, 
including culture medium, type of enzyme at harvesting 
(e.g., TryplE Select), time interval between seeding and 
harvest and passage
 
(Osipova et al., 2011). A study on 
culture of bone marrow MSCs indicated that 
proliferation potential in serum free medium was lower 
than in FCS supplemented medium
 
(Osipova et al., 
2011). However, another study showed that PRP was 
more mitogenic compared to FBS (Murphi et al., 2012) 
and this fact might explain the different proliferation rate 
in our study compared to other studies that used FBS 
supplementation (Scheers et al., 2013; Karahuseyinoglu 
et al., 2007). Moreover, serum and PRP batches may 
play a role in the difference. In our study, we did not 
compare different batches of PRP and this fact was a 
limitation to our study. 
Morphology of MSCs before aging is fibroblastic, 
but when the cells underwent aging as were shown by 
senescent staining, the aging cells became larger and 
broader and cell size (area) was significantly larger 
compared to non senescent cells. Scheers et al.
 
(2013) 
studied early passages of UC-MSCs and observed small 
fibroblastic cells with a diameter of 14.1± 0.7 µm that 
progressively flattened and enlarged to 22.3±0.8 µm upon 
aging.
 
Aging cells showed low proliferation rate, prolonged 
mitosis time and enlarged cell area (Scheers et al., 2013).
 
Scheers et al. (2013) study was corroborated by our 
study, which showed that SA-β-Gal positive group (P-10 
to P-17) had a larger cell area compared to SA-β-Gal 
negative group (P-2 to P-9). However, P-10 to P-17 
group still showed good viability and PDT,  which might 
be due to the low median (minimum-maximum) of 
senescent (SA-β-Gal positive) cell  percentage in this 
group that was 0.54 (0-3.41)%. 
In analysis we only included passages beginning at P-2. 
Passage-1 was not included as flow cytometric data of 
CD90, CD73 and CD34 showed that P-1 was 
heterogeneous. In P2, the cells were regarded as UC- MSCs 
from their fibroblastic morphology, adherent to plastic, flow 
cytometry analysis and differentiation capacity. 
In P-11, SA-β-Gal positive cells could not be 
assessed as the culture was too confluent, which caused 
detachment of monolayer from the well bottom and this 
fact was a limitation of our results. Senescent cells in P-
11 seemed to be higher compared to those in P-10. This 
fact might be due to relatively more confluent monolayer 
contained more cells, including the senescent cells. 
Another possibility was that over-confluent cultures 
tended to differentiate (Pawitan et al., 2014b) and after 
differentiation, the cells would lose their self renewal 
capacity and undergo aging.   
This study showed that for UC-MSCs the criteria for 
aging cells besides SA-β-Gal positive were:  Viability 
greater than 91% (minimum value),  PDT less than 2.1 
days (maximum value), fibroblastic morphology and cell 
size (area) less than 2602 µm
2 
(maximum value). 
Conclusion 
Umbilical cord derived MSCs that were cultured in 
α-MEM-10% PRP began to undergo aging at P-10. 
Morphological criteria of aging UC–MSCs were cell size 
greater than 2602 µm
2
 with a change in morphology 
toward a wider or rounded shape. 
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